Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiviral therapy completion and response rates among hepatitis C patients with and without schizophrenia.

Schizophrenia bulletin - 1 Jan 2010

Huckans Marilyn, Mitchell Alex, Ruimy Samantha, Loftis Jennifer, Hauser Peter

Abstract excerpt

BACKGROUND: Despite disproportionately high rates of hepatitis C (HCV) among patients with severe mental illness, to date, there is scant empirical data available regarding antiviral therapy outcomes within this population. OBJECTIVE: To compare antiviral therapy completion and response rates between HCV patients with vs those without schizophrenia (SCHZ). METHODS: A regional Veterans Healthcare Administration...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Interferon alpha-2

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Long-Term Care

Share to Patient Care Team

Share to Patient Compliance

Share to Polyethylene Glycols

Share to Ribavirin

Share to Schizophrenic Psychology

Source

Open in PubMed Open full text

Identifiers

PMID: 18562341
DOI: 10.1093/schbul/sbn065
PMCID: PMC2800135

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Antiviral therapy completion and response rates among hepatitis C patients with and without schizophrenia.PMID 18562341Read ↗

Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders.Semantic proximity Read ↗

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.Semantic proximity Read ↗

Feasibility and outcome of HCV treatment in a Canadian federal prison population.Semantic proximity Read ↗

Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities.Semantic proximity Read ↗

Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office.Semantic proximity Read ↗

Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders.Semantic proximity Read ↗

Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.Semantic proximity Read ↗

Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.